Samir Devani's questions to Valneva SE (VALN) leadership • Q1 2025
Question
Samir Devani from Rx Securities asked for confirmation on the fulfillment of the DUKORAL order for Mayotte, how to model the IXCHIQ order for La Réunion, and whether recent adverse events in the elderly have led to a reconsideration of the dose for upcoming pediatric studies.
Answer
CEO Thomas Lingelbach confirmed the DUKORAL order for Mayotte was fulfilled in Q1. CFO Peter Buhler added that the majority of the La Réunion IXCHIQ order was supplied in Q2. Regarding the pediatric dose, Mr. Lingelbach stated that they have not reconsidered the dose at this time, as no unexpected safety signals have been observed in younger adults or adolescents.